Proteros Inks Deal to Provide Access to UC DCC's Screening Platform | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein structure analysis firm Proteros today announced a deal with the University of Cincinnati, Drug Discovery Center to provide biotechnology and drug firms access to UC DDC's ultra-high throughput and high-content screening platform along with a library of more than 340,000 drug-like compounds.

Proteros, based in Martinsried, Germany, will serve as a single point of contact and be responsible for all client interactions and project management.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.